Date | Time | Source | Announcement |
---|---|---|---|
18 Jul 2013 | 07:00 AM | Positive anti-inflammatory and anti-viral data | |
03 Jul 2013 | 03:05 PM | Holding(s) in Company | |
10 Jun 2013 | 01:45 PM | Result of AGM | |
21 May 2013 | 11:10 AM | Holding(s) in Company | |
09 May 2013 | 12:45 PM | Notice of AGM | |
09 Apr 2013 | 04:26 PM | Posting of Annual Report | |
12 Mar 2013 | 07:00 AM | Grant of Options | |
13 Feb 2013 | 07:00 AM | Preliminary Results | |
05 Dec 2012 | 07:00 AM | Trading Update | |
30 Oct 2012 | 01:44 PM | Director/PDMR Shareholding | |
25 Sep 2012 | 07:00 AM | Exercise of Options | |
31 Aug 2012 | 07:00 AM | Synairgen presents proof of concept study | |
10 Aug 2012 | 07:00 AM | Half Yearly Report | |
18 Jul 2012 | 07:00 AM | Placing | |
25 Jun 2012 | 01:30 PM | Result of AGM | |
22 May 2012 | 07:30 AM | Professor Stephen Holgate given prestigious Award | |
01 May 2012 | 12:55 PM | Holding(s) in Company | |
19 Apr 2012 | 07:00 AM | Positive Phase II asthma data | |
02 Mar 2012 | 07:00 AM | Notice of Report and Accounts | |
01 Feb 2012 | 07:00 AM | Preliminary results | |
30 Jan 2012 | 07:00 AM | Notice of Results | |
12 Dec 2011 | 07:00 AM | Director's dealing | |
08 Dec 2011 | 07:00 AM | End of Recruitment in Phase II Asthma Trial | |
25 Nov 2011 | 07:00 AM | Positive Viral Pneumonia Study Results | |
10 Nov 2011 | 12:40 PM | Result of AGM | |
18 Oct 2011 | 01:50 PM | Notice of AGM and posting of Annual Reports | |
22 Sep 2011 | 03:10 PM | Grant of options | |
13 Sep 2011 | 07:00 AM | Preliminary Results | |
09 Sep 2011 | 07:00 AM | Change of Adviser | |
18 Jul 2011 | 07:00 AM | Japanese Patent to be Granted | |
28 Jun 2011 | 07:00 AM | Phase II asthma study - Interim Review and update | |
15 Jun 2011 | 03:56 PM | Holding(s) in Company | |
13 Jun 2011 | 11:54 AM | Result of General Meeting | |
27 May 2011 | 01:00 PM | Fundraising | |
04 May 2011 | 07:00 AM | Antiviral activity against Bird Flu | |
02 Feb 2011 | 11:31 AM | Holding(s) in Company | |
01 Feb 2011 | 07:00 AM | Half Yearly Report | |
03 Nov 2010 | 01:35 PM | Result of AGM | |
19 Oct 2010 | 07:00 AM | US Patent | |
08 Oct 2010 | 09:00 AM | Notice of AGM and Posting of | |
09 Sep 2010 | 07:00 AM | Grant of Options | |
29 Jul 2010 | 07:00 AM | Final Results | |
27 Jul 2010 | 07:00 AM | Notice of Results | |
29 Jun 2010 | 07:00 AM | Grant of Options | |
28 Jun 2010 | 07:00 AM | Directorate Change | |
17 May 2010 | 07:00 AM | Positive Influenza Data | |
06 May 2010 | 07:00 AM | IFN-beta Patent Granted in Eu | |
01 Apr 2010 | 07:00 AM | Phase II Trials | |
24 Feb 2010 | 03:27 PM | Holding(s) in Company | |
08 Feb 2010 | 07:00 AM | Half Yearly Report |
Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.
Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.
Synairgen share price launched at 155p in 2004.